“Equity-informative health technology assessment – A commentary on Ngalesoni, Ruhago, Mori, Robberstad & Norheim”

Social Science and Medicine

Volumn 170, Issue , 2016, Pages 218-219

  Cookson, Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DISTRIBUTIONAL COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EXTENDED COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH EQUITY; HEALTH SERVICE; HEALTH TECHNOLOGY ASSESSMENT; HIGH INCOME COUNTRY; LOW INCOME COUNTRY; NOTE;

EID: 84994589566     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2016.10.022     Document Type: Note

References (12)

1. Asaria, M., Griffin, S., Cookson, R., Measuring Health Inequality in the Context of Cost-effectiveness Analysis. Health and Inequality (Research on Economic Inequality, Volume 21), vol. 21, 2013, Emerald Group Publishing Limited, 491–507.
2. Asaria, M., Griffin, S., Cookson, R., Distributional cost-effectiveness analysis: a tutorial. Med. Decis. Mak. 36.1 (2016), 8–19.
3. Cleary, S., Mooney, G., McIntyre, D., Equity and efficiency in HIV-treatment in South Africa: the contribution of mathematical programming to priority setting. Health Econ. 19 (2010), 1166–1180.
4. Cookson, R., Griffin, S., Nord, E., Incorporation of concerns for fairness in economic evaluation of health programs: overview. Culyer, A.J., (eds.) Encyclopedia of Health Economics, 2014, Elsevier, San Diego, 27–34.
5. Cookson, R.A., Mirelman, A., Asaria, M., Dawkins, B., Griffin, S., Fairer Decisions, Better Health For All: Health Equity and Cost-effectiveness Analysis. 2016, Centre for Health Economics, University of York, 1–43 (CHE Research Paper; No. 135).
6. Daniels, N., Porteny, T., Urritia, J., Expanded HTA: enhancing fairness and legitimacy. Int. J. Health Policy Manag. 5 (2016), 1–3.
7. Horton, R., Offline: the error of our health technology assessment ways. Lancet, 382, 2013, 1318.
8. Johri, M., Norheim, O., Can cost-effectiveness analysis integrate concerns for equity? Systematic review. Int. J. Technol. Assess. Health Care 28 (2012), 125–132.
9. Norheim, O., Ottersen, T., Berhane, F., Chitah, B., Cookson, R., Daniels, N., Eyal, N., Flores, W., Gosseries, A., Hausman, D., Making Fair Choices on the Path to Universal Health Coverage: Final Report of the WHO Consultative Group on Equity and Universal Health Coverage., 2014, World Health Organization.
10. Verguet, S., Jamison, D.T., Health policy analysis: applications of extended cost-effectiveness analysis methodology in DCP3. Jamison, D.T., Gelband, H., Horton, S., Jha, P., Laxminarayan, R., Mock, C., Nugent, R., (eds.) Disease Control Priorities, third ed. Improving Health and Reducing Poverty, vol. 9, 2017, World Bank, Washington, DC.
11. Verguet, S., Kim, J.J., Jamison, D.T., Extended cost-effectiveness analysis for health policy assessment: a tutorial. Pharmacoeconomics, 2016, 1–11.
12. World Health Organization, Tracking Universal Health Coverage: First Global Monitoring Report., 2015, World Health Organization.